COVID-19

Outside of the loss of human life due to the COVID-19 pandemic, the past two years have greatly affected hospitals, health systems and the way providers deliver care. Healthcare executives are grappling with federal monetary assistance, growing burnout rates, workforce shortages and federal oversight of vaccines and testing. This channel is also designed to update clinicians on new research and guidelines regarding COVID patient treatment strategies and risk assessments.

Pfizer formally submits COVID-19 pill to FDA for emergency use authorization

An initial analysis revealed Paxlovid reduced the risk of hospitalization or death in high-risk patients who took the pill within 3 days of experiencing symptoms.

Thumbnail

40% of providers plan to keep COVID-19 protocols in place post-pandemic

Additionally, 71% of medical professionals said safety standards increased during the health crisis.

FDA recalls 2.2M at-home COVID tests due to false positive results

Ellume was the first company to gain federal authorization for an over-the-counter test to detect COVID-19.

coronavirus COVID-19 vaccine vaccination

COVID-19 vaccines are less effective on the immunocompromised

These individuals are less likely to benefit from COVID-19 vaccines, according to a recent study from the Centers for Disease Control and Prevention.

kids in school

FDA authorizes Pfizer COVID-19 vaccine for children 5 to 11

The administration said it studied the vaccine's safety in more than 3,100 children, and no serious side effects have been reported thus far.

COVID lockdown reopening

Small cash incentives kept vaccination rates from nosediving, pilot study shows

More than 40% surveyed said the cash card played an important role in their decision, experts explained in JAMA Internal Medicine.

Thumbnail

Dangled dollars did next to nothing for COVID vax campaigns

Big-payout lotteries aimed at incentivizing Americans to get vaccinated for COVID-19 have largely flopped, according to a research letter running in JAMA Health Forum.

More than half of COVID survivors struggle to shake off direct, indirect symptoms

A systematic review of 57 studies representing more than a quarter-million COVID cases has turned up some distressing statistics on survivors—not least those considered “long-haulers.”  

Around the web

In the post-COVID era, wages for permanent RNs are rising, and wages for travelers are decreasing. A new report tracked these trends and more. 

Two medical device companies have announced a transaction that could shake up the U.S. electrophysiology market. 

These companies were already part of the Johnson & Johnson family, but they had still retained their previous brand names. Now, each one is officially going by Johnson & Johnson MedTech. 

Trimed Popup
Trimed Popup